Does the media favor QSI or RPID?

In the previous week, Quantum-Si had 5 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 9 mentions for Quantum-Si and 4 mentions for Rapid Micro Biosystems. Quantum-Si's average media sentiment score of 0.68 beat Rapid Micro Biosystems' score of 0.67 indicating that Quantum-Si is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quantum-Si 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rapid Micro Biosystems 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CDXS or RPID?

In the previous week, Codexis and Codexis both had 4 articles in the media. Rapid Micro Biosystems' average media sentiment score of 0.67 beat Codexis' score of 0.00 indicating that Rapid Micro Biosystems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Codexis 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Rapid Micro Biosystems 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer RPID or MXCT?

In the previous week, Rapid Micro Biosystems had 3 more articles in the media than MaxCyte. MarketBeat recorded 4 mentions for Rapid Micro Biosystems and 1 mentions for MaxCyte. Rapid Micro Biosystems' average media sentiment score of 0.67 beat MaxCyte's score of 0.00 indicating that Rapid Micro Biosystems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rapid Micro Biosystems 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive MaxCyte 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer RPID or NAUT?

In the previous week, Nautilus Biotechnology had 4 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 8 mentions for Nautilus Biotechnology and 4 mentions for Rapid Micro Biosystems. Rapid Micro Biosystems' average media sentiment score of 0.67 beat Nautilus Biotechnology's score of 0.40 indicating that Rapid Micro Biosystems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rapid Micro Biosystems 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Nautilus Biotechnology 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Rapid Micro Biosystems (RPID) Competitors

$0.92 0.00 (-0.11%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$0.92 +0.01 (+0.54%)

As of 10/2/2026 07:30 PM Eastern

Compare

RPID vs. QSI, CDXS, QTRX, MXCT, and NAUT

Should you buy Rapid Micro Biosystems stock or one of its competitors? Rapid Micro Biosystems's main competitors and comparable companies include Quantum-Si (QSI), Codexis (CDXS), Quanterix (QTRX), MaxCyte (MXCT), and Nautilus Biotechnology (NAUT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Rapid Micro Biosystems compare to Quantum-Si?

Quantum-Si (NASDAQ:QSI) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

Rapid Micro Biosystems has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum-Si	$2.44M	139.04	-$101.34M	-$0.46	N/A
Rapid Micro Biosystems	$33.59M	1.37	-$47.12M	-$1.12	N/A

Quantum-Si currently has a consensus price target of $2.50, indicating a potential upside of 61.29%. Rapid Micro Biosystems has a consensus price target of $5.00, indicating a potential upside of 443.48%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, analysts plainly believe Rapid Micro Biosystems is more favorable than Quantum-Si.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75

Rapid Micro Biosystems has a net margin of -145.56% compared to Quantum-Si's net margin of -6,138.26%. Quantum-Si's return on equity of -47.12% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum-Si	-6,138.26%	-47.12%	-43.18%
Rapid Micro Biosystems	-145.56%	-177.04%	-73.12%

39.9% of Quantum-Si shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 22.0% of Quantum-Si shares are owned by company insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Quantum-Si has a beta of 3.21, suggesting that its stock price is 221% more volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.5, suggesting that its stock price is 50% more volatile than the broader market.

In the previous week, Quantum-Si had 5 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 9 mentions for Quantum-Si and 4 mentions for Rapid Micro Biosystems. Quantum-Si's average media sentiment score of 0.68 beat Rapid Micro Biosystems' score of 0.67 indicating that Quantum-Si is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantum-Si	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Quantum-Si and Rapid Micro Biosystems tied by winning 8 of the 16 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Codexis?

Codexis (NASDAQ:CDXS) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment.

78.5% of Codexis shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 3.5% of Codexis shares are owned by insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Codexis and Codexis both had 4 articles in the media. Rapid Micro Biosystems' average media sentiment score of 0.67 beat Codexis' score of 0.00 indicating that Rapid Micro Biosystems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Codexis	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Codexis presently has a consensus target price of $6.50, indicating a potential upside of 377.94%. Rapid Micro Biosystems has a consensus target price of $5.00, indicating a potential upside of 443.48%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, analysts clearly believe Rapid Micro Biosystems is more favorable than Codexis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Codexis	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75

Codexis has a beta of 2.55, suggesting that its share price is 155% more volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.5, suggesting that its share price is 50% more volatile than the broader market.

Codexis has higher revenue and earnings than Rapid Micro Biosystems. Codexis is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Codexis	$70.39M	2.12	-$43.97M	-$0.34	N/A
Rapid Micro Biosystems	$33.59M	1.37	-$47.12M	-$1.12	N/A

Codexis has a net margin of -39.55% compared to Rapid Micro Biosystems' net margin of -145.56%. Codexis' return on equity of -74.36% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Codexis	-39.55%	-74.36%	-23.58%
Rapid Micro Biosystems	-145.56%	-177.04%	-73.12%

Summary

Codexis beats Rapid Micro Biosystems on 9 of the 15 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Quanterix?

Rapid Micro Biosystems (NASDAQ:RPID) and Quanterix (NASDAQ:QTRX) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

In the previous week, Rapid Micro Biosystems had 4 more articles in the media than Quanterix. MarketBeat recorded 4 mentions for Rapid Micro Biosystems and 0 mentions for Quanterix. Rapid Micro Biosystems' average media sentiment score of 0.67 beat Quanterix's score of 0.51 indicating that Rapid Micro Biosystems is being referred to more favorably in the media.

Company	Overall Sentiment
Rapid Micro Biosystems	Positive
Quanterix	Positive

Rapid Micro Biosystems has higher earnings, but lower revenue than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid Micro Biosystems	$33.59M	1.37	-$47.12M	-$1.12	N/A
Quanterix	$153.17M	1.12	-$107.15M	-$2.63	N/A

Rapid Micro Biosystems has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market. Comparatively, Quanterix has a beta of 1.01, indicating that its share price is 1% more volatile than the broader market.

Quanterix has a net margin of -80.25% compared to Rapid Micro Biosystems' net margin of -145.56%. Quanterix's return on equity of -26.09% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rapid Micro Biosystems	-145.56%	-177.04%	-73.12%
Quanterix	-80.25%	-26.09%	-19.03%

Rapid Micro Biosystems presently has a consensus price target of $5.00, suggesting a potential upside of 443.48%. Quanterix has a consensus price target of $3.00, suggesting a potential downside of 17.58%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, analysts plainly believe Rapid Micro Biosystems is more favorable than Quanterix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75
Quanterix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 86.5% of Quanterix shares are held by institutional investors. 12.7% of Rapid Micro Biosystems shares are held by company insiders. Comparatively, 1.5% of Quanterix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Rapid Micro Biosystems beats Quanterix on 12 of the 17 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to MaxCyte?

Rapid Micro Biosystems (NASDAQ:RPID) and MaxCyte (NASDAQ:MXCT) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

MaxCyte has a net margin of -114.77% compared to Rapid Micro Biosystems' net margin of -145.56%. MaxCyte's return on equity of -18.92% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rapid Micro Biosystems	-145.56%	-177.04%	-73.12%
MaxCyte	-114.77%	-18.92%	-16.14%

Rapid Micro Biosystems has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market. Comparatively, MaxCyte has a beta of 1.49, indicating that its share price is 49% more volatile than the broader market.

52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 68.8% of MaxCyte shares are held by institutional investors. 12.7% of Rapid Micro Biosystems shares are held by company insiders. Comparatively, 4.1% of MaxCyte shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Rapid Micro Biosystems had 3 more articles in the media than MaxCyte. MarketBeat recorded 4 mentions for Rapid Micro Biosystems and 1 mentions for MaxCyte. Rapid Micro Biosystems' average media sentiment score of 0.67 beat MaxCyte's score of 0.00 indicating that Rapid Micro Biosystems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
MaxCyte	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

MaxCyte has lower revenue, but higher earnings than Rapid Micro Biosystems. MaxCyte is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid Micro Biosystems	$33.59M	1.37	-$47.12M	-$1.12	N/A
MaxCyte	$33.03M	3.34	-$44.63M	-$0.33	N/A

Rapid Micro Biosystems currently has a consensus target price of $5.00, suggesting a potential upside of 443.48%. MaxCyte has a consensus target price of $5.00, suggesting a potential upside of 367.29%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, equities research analysts plainly believe Rapid Micro Biosystems is more favorable than MaxCyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75
MaxCyte	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Rapid Micro Biosystems beats MaxCyte on 10 of the 17 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Rapid Micro Biosystems (NASDAQ:RPID) and Nautilus Biotechnology (NASDAQ:NAUT) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 50.7% of Nautilus Biotechnology shares are held by institutional investors. 12.7% of Rapid Micro Biosystems shares are held by insiders. Comparatively, 41.1% of Nautilus Biotechnology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Rapid Micro Biosystems presently has a consensus price target of $5.00, suggesting a potential upside of 443.48%. Nautilus Biotechnology has a consensus price target of $3.83, suggesting a potential upside of 95.58%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, equities research analysts plainly believe Rapid Micro Biosystems is more favorable than Nautilus Biotechnology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75
Nautilus Biotechnology	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

Rapid Micro Biosystems has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid Micro Biosystems	$33.59M	1.37	-$47.12M	-$1.12	N/A
Nautilus Biotechnology	N/A	N/A	-$59M	-$0.45	N/A

Nautilus Biotechnology has a net margin of 0.00% compared to Rapid Micro Biosystems' net margin of -145.56%. Nautilus Biotechnology's return on equity of -37.58% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rapid Micro Biosystems	-145.56%	-177.04%	-73.12%
Nautilus Biotechnology	N/A	-37.58%	-30.83%

Rapid Micro Biosystems has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market. Comparatively, Nautilus Biotechnology has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market.

In the previous week, Nautilus Biotechnology had 4 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 8 mentions for Nautilus Biotechnology and 4 mentions for Rapid Micro Biosystems. Rapid Micro Biosystems' average media sentiment score of 0.67 beat Nautilus Biotechnology's score of 0.40 indicating that Rapid Micro Biosystems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Nautilus Biotechnology	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Rapid Micro Biosystems beats Nautilus Biotechnology on 8 of the 14 factors compared between the two stocks.

Get Rapid Micro Biosystems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RPID vs. The Competition

Export

Metric	Rapid Micro Biosystems	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$46.15M	$10.57B	$7.14B	$13.17B
Dividend Yield	N/A	1.45%	2.53%	16.78%
P/E Ratio	-0.82	74.99	275.68	26.04
Price / Sales	1.31	459.91	662.25	102.14
Price / Cash	N/A	26.96	77.60	51.75
Price / Book	1.23	6.85	10.93	6.31
Net Income	-$47.12M	$57.48B	$3.51B	$362.16M
7 Day Performance	-17.12%	2.53%	-2.00%	-1.66%
1 Month Performance	-33.33%	8.43%	-6.15%	-4.50%
1 Year Performance	-75.73%	32.93%	7.44%	2.06%

Rapid Micro Biosystems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RPID Rapid Micro Biosystems	3.0425 of 5 stars	$0.92 -0.1%	$5.00 +443.5%	-73.9%	$46.15M	$35.18M	N/A	171	News Coverage Analyst Upgrade Gap Up
QSI Quantum-Si	2.967 of 5 stars	$0.78 +3.8%	$1.00 +27.4%	+0.6%	$165.45M	$2.44M	N/A	145	News Coverage Analyst Forecast Options Volume
CDXS Codexis	1.8211 of 5 stars	$1.39 +0.7%	$6.50 +367.6%	-46.0%	$151.12M	$70.39M	N/A	146
QTRX Quanterix	0.3048 of 5 stars	$3.19 +4.9%	$3.00 -6.0%	-35.6%	$143.77M	$138.90M	N/A	450
MXCT MaxCyte	2.7593 of 5 stars	$1.24 +1.6%	$5.00 +303.2%	-33.5%	$125.91M	$33.03M	N/A	91	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RPID) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rapid Micro Biosystems (RPID) Competitors

RPID vs. QSI, CDXS, QTRX, MXCT, and NAUT

How does Rapid Micro Biosystems compare to Quantum-Si?

Summary

How does Rapid Micro Biosystems compare to Codexis?

Summary

How does Rapid Micro Biosystems compare to Quanterix?

Summary

How does Rapid Micro Biosystems compare to MaxCyte?

Summary

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPID vs. The Competition

Rapid Micro Biosystems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rapid Micro Biosystems (RPID) Competitors

RPID vs. QSI, CDXS, QTRX, MXCT, and NAUT

How does Rapid Micro Biosystems compare to Quantum-Si?

Which has stronger valuation and earnings, QSI or RPID?

Do analysts prefer QSI or RPID?

Is QSI or RPID more profitable?

Do institutionals and insiders have more ownership in QSI or RPID?

Which has more volatility and risk, QSI or RPID?

Does the media favor QSI or RPID?

Summary

How does Rapid Micro Biosystems compare to Codexis?

Do institutionals & insiders have more ownership in CDXS or RPID?

Does the media favor CDXS or RPID?

Do analysts prefer CDXS or RPID?

Which has more risk & volatility, CDXS or RPID?

Which has better earnings & valuation, CDXS or RPID?

Is CDXS or RPID more profitable?

Summary

How does Rapid Micro Biosystems compare to Quanterix?

Does the media refer more to RPID or QTRX?

Which has preferable earnings & valuation, RPID or QTRX?

Which has more volatility and risk, RPID or QTRX?

Is RPID or QTRX more profitable?

Do analysts recommend RPID or QTRX?

Do insiders & institutionals have more ownership in RPID or QTRX?

Summary

How does Rapid Micro Biosystems compare to MaxCyte?

Is RPID or MXCT more profitable?

Which has more volatility and risk, RPID or MXCT?

Do institutionals and insiders have more ownership in RPID or MXCT?

Does the media prefer RPID or MXCT?

Which has better valuation and earnings, RPID or MXCT?

Do analysts rate RPID or MXCT?

Summary

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Do institutionals & insiders hold more shares of RPID or NAUT?

Do analysts rate RPID or NAUT?

Which has higher earnings & valuation, RPID or NAUT?

Is RPID or NAUT more profitable?

Which has more risk & volatility, RPID or NAUT?

Does the media prefer RPID or NAUT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPID vs. The Competition

Rapid Micro Biosystems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools